VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Brucella abortus gonadotropin releasing hormone subunit vaccine
Vaccine Information
  • Vaccine Name: Brucella abortus gonadotropin releasing hormone subunit vaccine
  • Target Pathogen: Brucella spp.
  • Target Disease: Brucellosis
  • Vaccine Ontology ID: VO_0009213
  • Type: Subunit vaccine
  • Status: Research
  • Host Species for Licensed Use: Deer
  • Antigen: gonadotropin-releasing hormone
  • Preparation: Single immunization of either 1,000 microg or 2,000 microg doses of GonaCon. (Killian et al, 2009)
  • Description: The vaccine was used to immunize captive female elk to evaluate contraceptive efficacy as a method to reduce brucellosis transmission and manage elk populations. Efficacy: Both doses prevented pregnancy in elk cows for at least three years with infertility rates of 86-100% in treated groups versus 0-28% in controls (P<0.0001). Immune response: Antibody titers were measured but specific immune response details are not reported in the abstract. (Killian et al, 2009)
Host Response
References
Killian et al, 2009: Killian G, Kreeger TJ, Rhyan J, Fagerstone K, Miller L. Observations on the use of GonaCon in captive female elk (Cervus elaphus). Journal of wildlife diseases. 2009 Jan; 45(1); 184-8. [PubMed: 19204347].